Now I have sufficient calibration. Let me write the final review.

**Final Calibration Assessment:**
- Papers with good core metrics but limited clinical/downstream validation typically score 4.0-4.5 (H3CisTbYkR.md at 4.00, 5PY8HR2Zz6.md at 4.50)
- Papers with evaluation-scope mismatches (claiming X but evaluating Y) score 3.0-4.0 (SboD1FBYdy.md at 3.00, NnsuEaN1Wx.md at 3.33)
- This paper demonstrates real technical achievement (scanner label removal to ~25% with 0.986 SSIM) but has the same structural gap as lower-scoring papers: claims about improving disease diagnosis generalization without evaluating any diagnostic task

The paper is stronger than UlMCtFDBRn.md (2.50) because the core method works for what it measures. It's weaker than vcdMBXeiet.md (5.00) which had thorough evaluation across multiple architectures and adaptive attacks. Positioned against H3CisTbYkR.md (4.00) which had good metrics but limited clinical validation (one expert), this paper is comparable - good technical results but insufficient validation for the claimed scope.

**Final Score: 4.0** - The paper demonstrates a working method for scanner label removal with high fidelity, but the evaluation does not support the core claim about improving disease diagnosis generalization. This is a significant gap that prevents acceptance, though the technical contribution has merit.

## Summary

This paper presents GECO, a generative adversarial network designed to remove scanner manufacturer and field strength artifacts from MRI images. The method reduces classifier accuracy on manufacturer identification from 98.84% to 25.6% (near random chance for 4 classes) while maintaining high structural similarity (0.986 SSIM, 37.75 PSNR). A small radiologist study found no preference between original and generated images.

## Strengths

- **Effective scanner label removal:** The core GECO architecture demonstrably reduces manufacturer classification accuracy from 98.84% baseline to 25.6% (Table 1), achieving the stated goal of obscuring scanner identity. This is concrete evidence that the adversarial training successfully fools the classifier.

- **High image fidelity metrics:** The method achieves 0.986 SSIM and 37.75 PSNR, indicating minimal pixel-wise distortion. The systematic architecture ablation (Table 1) shows the Core GAN outperforms Residual and Three-Player variants in balancing fidelity and de-artifacting efficacy.

- **Architecture exploration:** The paper provides useful ablation data comparing generator variants (Core, Residual, Multi-Residual, Three-Player), demonstrating that more complex variants suffered from mode collapse or degraded SSIM below 0.95 (Section 4.1).

## Weaknesses

### Fatal

None

### Major

- **Evaluation does not validate core claim:** The paper's Introduction states the problem is that "models often fail to generalize beyond the training dataset" for "disease and pathology detection" (lines 19-20), citing Badgeley et al. (2018) on spurious correlations hindering disease diagnosis. However, evaluation only measures scanner classification accuracy, not downstream diagnostic task performance (e.g., tumor classification or segmentation accuracy across sites). Successfully obscuring scanner identity does not demonstrate preserved diagnostic utility or improved disease classification generalization. This structural disconnect between the metric (classifier accuracy) and the claimed contribution (improving medical ML generalizability for diagnosis) is a fundamental gap. Papers with this evaluation-scope mismatch typically score 3.0-4.0 in human reviews (e.g., SboD1FBYdy.md at 3.00, NnsuEaN1Wx.md at 3.33).

- **No robustness check against different architectures:** The method demonstrates accuracy drop against one specific classifier architecture (DeepDicomSort-based) trained in an adversarial loop. However, there is no evaluation using different classifier architectures (e.g., Vision Transformer, EfficientNet) that were not part of the adversarial training. This raises the possibility of gradient masking rather than true information removal—a known concern in adversarial robustness literature. The claim that artifacts are "removed" (Abstract) requires demonstrating the signal is unrecoverable by any reasonable classifier, not just the one used during training.

### Minor

- **Underpowered radiologist study:** The radiologist evaluation (Figure 3, lines 292-305) includes only 52 total judgments across 5 radiologists (10+8+34=52). Radiologists scored "visual quality" and "preference," not diagnostic confidence or pathology visibility. High SSIM and aesthetic quality do not guarantee preservation of subtle pathological features (e.g., enhancing tumor boundaries, white matter hyperintensities) that may be altered by the generator. This evidence is insufficient to support the claim that images retain "value as a diagnostic tool" (line 179). Similar limitations in clinical validation led to scores of 4.0 in comparable papers (H3CisTbYkR.md).

- **Unclear data split protocol:** Section 3.3 states a "70/20/10 rule" for training/validation/test splits (line 101) but does not specify whether splits are patient-independent. MRI datasets contain multiple slices per patient; if slices from the same patient appear in both training and test sets, the classifier can learn patient-specific anatomy rather than scanner features, potentially inflating baseline accuracy and making the generator's task misleading.

- **Ambiguous loss notation:** Equation 1 (line 54) uses notation $\sum_{i=1}^c \log(ClAs(Gen(X_i)))$ where $c$ is the number of classes, but $X_i$ suggests an image per class. Standard practice sums over a batch of $N$ images or over class probabilities for a single image. This ambiguity complicates reproduction.

### Trivial

- **Terminology conflation:** The Abstract claims "solving the known problem of removing artifacts from MRI images," but the paper addresses domain anonymization (scanner manufacturer labels), not physical artifact removal (e.g., motion, metal, zipper artifacts). This conflation may mislead readers about the method's scope.

## Nice-to-Haves

- Evaluate downstream diagnostic task generalization: Train a disease classifier on GECO-processed data from one site and test on another to directly validate the claimed benefit for model generalizability.

- Analyze specific regions of interest (e.g., tumor boundaries, lesions) to quantify whether the generator alters clinically relevant contrast, rather than relying solely on global SSIM/PSNR.

- Include failure cases showing examples where GECO altered diagnostic information to fool the classifier, which is critical for risk assessment in clinical applications.

- Clarify whether training/test splits are patient-independent to prevent data leakage concerns.

## Removed Points

These points are flagged to be removed, treat them with caution:

- **Harsh Critic Issue #5 (Conclusion about treating physiological features as artifacts):** This is a speculative future direction in the Conclusion, not a methodological flaw. The paper appropriately frames this as potential future work, not a current claim.

- **Strength Finder "Clinical validation of image fidelity":** The radiologist study is too underpowered (52 judgments, visual quality not diagnostic assessment) to constitute clinical validation. This overstates the evidence.

- **Strength Finder "Problem Relevance" as generic strength:** While domain shift is important, this is a generic statement not specific to this paper's contribution. Removed per instructions to drop generic strengths.

- **Harsh Critic's point about "unfair comparison":** The paper uses a baseline classifier as comparison (Section 3.2), which is appropriate since no prior generative editing baselines exist for this task. This is not an unfair comparison.

- **Any criticism about missing appendix/proofs:** The parser strips appendices from all papers; they exist in the original submission. Removed per hard rules.

## Novel Insights

The paper identifies a genuine tension in medical image harmonization: adversarial removal of domain-specific features may obscure scanner labels without preserving diagnostically relevant information. The high SSIM (0.986) combined with near-random classifier accuracy (25.6%) suggests the method successfully targets features the classifier uses, but without downstream diagnostic evaluation, it remains unclear whether these features overlap with clinically relevant signals. This highlights a broader challenge in the field: fidelity metrics like SSIM/PSNR measure pixel-wise similarity but do not capture preservation of subtle pathological features that may be altered by generative editing.

## Suggestions

1. **Add downstream diagnostic evaluation:** The most critical improvement would be to evaluate disease classification or segmentation performance on GECO-processed images across different sites/scanners. This directly addresses the core claim about improving model generalizability.

2. **Test with held-out classifier architectures:** Evaluate GECO-processed images using classifier architectures not seen during adversarial training (e.g., ViT, EfficientNet) to verify the scanner signal is truly removed rather than masked for one specific architecture.

3. **Expand radiologist study:** Increase the number of judgments and have radiologists assess diagnostic confidence or pathology visibility rather than just aesthetic quality. Consider a task-based evaluation where radiologists detect lesions in original vs. GECO-processed images.

4. **Clarify data splits:** Explicitly state whether training/validation/test splits are patient-independent to address potential data leakage concerns.

5. **Fix loss notation:** Clarify Equation 1 to specify whether the sum is over batch samples or class probabilities, improving reproducibility.

## Score and Decision

**Calibration Process:**

I retrieved anchors across three score bands:

**High-scoring anchors (≥6.0):**
- n0vHjCiLD2.md (6.00): Online adaptation for interactive segmentation validated on 9 datasets (5 fundus + 4 brain MRI) with downstream segmentation performance. Comprehensive evaluation matching claimed scope.
- vcdMBXeiet.md (5.00): Training-free adversarial defense for MRI reconstruction with thorough evaluation across multiple datasets, architectures, and adaptive attacks.

**Medium-scoring anchors (4.5-5.5):**
- Z2XIRLv535.md (5.50): Gaussian masked autoencoders with comprehensive evaluation but novelty concerns.
- weWUOuLTdj.md (5.00): Generative model with scalability issues limiting practical impact.
- H3CisTbYkR.md (4.00): Generative clinical simulation with good metrics but limited clinical validation (one expert, proxy evaluation).

**Low-scoring anchors (≤4.0):**
- NnsuEaN1Wx.md (3.33): Privacy-preserving MRI harmonization with unrealistic black-box setting assumptions.
- SboD1FBYdy.md (3.00): Medical MLLM with evaluation focused on VQA without broader clinical tasks.
- UlMCtFDBRn.md (2.50): Adversarial attack detection with fundamental methodological flaws.

**Positioning:** This paper demonstrates real technical achievement (scanner label removal to 25.6% with 0.986 SSIM), positioning it above papers with fundamental flaws (UlMCtFDBRn.md at 2.50). However, the evaluation-scope mismatch (claiming improved disease diagnosis generalization without evaluating diagnostic tasks) is comparable to SboD1FBYdy.md (3.00) and NnsuEaN1Wx.md (3.33). The paper is most similar to H3CisTbYkR.md (4.00), which had good core metrics but limited clinical validation. Like that paper, GECO shows promising technical results but lacks the validation needed to support its broader claims.

Compared to high-scoring anchors like n0vHjCiLD2.md (6.00) with comprehensive downstream validation, this paper's evaluation gap is decisive. The core method works for scanner label removal, but the leap to "improving model generalizability" for diagnosis is unsupported by evidence.

**Final Score:** 4.0 — The paper demonstrates a working method with concrete results, but the evaluation does not support the core claim about improving disease diagnosis generalization. This is a significant gap preventing acceptance, though the technical contribution has merit for future work with proper validation.

MY FINAL SCORE: <pineapple>4.0</pineapple>
MY FINAL DECISION: <orange>Reject</orange>